NORDSON CORP Reports 12.1% Sales Increase

By Philip Seaworth • Thursday, August 21 15:39 • Permanent Link

NORDSON CORP recently released its 10-Q report, detailing the company's operations and financial performance. NORDSON CORP is an innovative precision technology company that engineers, manufactures, and markets products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products. The company operates through three segments: Industrial Precision Solutions; Medical and Fluid Solutions; and Advanced Technology Solutions. NORDSON CORP was founded in 1909 and is headquartered in Westlake, Ohio.

In the report, NORDSON CORP's consolidated financial results for the three months ended July 31, 2025, showed sales of $741,509, a 12.1% increase from the same period in 2024. The gross margin was $406,517, representing a 10.2% increase, with a gross margin percentage of 54.8%. The operating profit for the same period was $187,767, a 12.4% increase from 2024. For the nine months ended July 31, 2025, sales were $2,039,867, a 4.9% increase, with a gross margin of $1,116,317, a 3.0% increase and a gross margin percentage of 54.7%. The operating profit for the nine months was $497,464, a 0.5% increase from the same period in 2024.

The net sales for the Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions segments for the three months and nine months ended July 31, 2025, were analyzed. The report also detailed the net sales by region, operating profit, interest expense, other-net, income tax expense, net income, foreign currency effects, and financial condition, including liquidity and capital resources.

The report also discussed the impact of foreign currency exchange rate changes, changes in trade policies, tariffs, and other import/export regulations, and the company's liquidity and capital resources, including cash and cash equivalents. The report highlighted that approximately 82 percent of the company's consolidated cash and cash equivalents were held at various foreign subsidiaries as of July 31, 2025.

The market has reacted to these announcements by moving the company's shares 3.71% to a price of $221.43. For more information, read the company's full 10-Q submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.